These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1316110)

  • 1. Human T-lymphotropic virus type I/II. Status of enzyme immunoassay and western blot testing in the United States in 1989 and 1990.
    Blumer SO; Hearn TL; Schalla WO; Cross GD; Valdiserri RO
    Arch Pathol Lab Med; 1992 May; 116(5):471-6. PubMed ID: 1316110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004.
    Stramer SL; Foster GA; Dodd RY
    Transfusion; 2006 May; 46(5):703-7. PubMed ID: 16686837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of laboratory performance in testing for human immunodeficiency virus type 1 antibody. Identification of variables associated with laboratory performance.
    Hancock JS; Taylor RN; Johnson CA; Gerber AR; Schalla WO
    Arch Pathol Lab Med; 1993 Nov; 117(11):1148-55. PubMed ID: 8239938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: Public Health Service workshop on human T-lymphotropic virus type III antibody testing--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Aug; 34(31):477-8. PubMed ID: 2991728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody.
    Cross GD; Schalla WO; Hancock JS; Hearn TL; Blumer SO; Taylor RN; Valdiserri RO
    Arch Pathol Lab Med; 1992 May; 116(5):477-81. PubMed ID: 1580749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update: serologic testing for human T-lymphotropic virus type I--United States, 1989 and 1990.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Apr; 41(15):259-62. PubMed ID: 1557018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the level of immunosuppression in human immunodeficiency virus-infected patients affect the reliability of human T-cell lymphotropic virus type 2 serological diagnosis?
    Bassani S; Toro C; Jiménez V; Rodés B; Soriano V
    Clin Vaccine Immunol; 2006 Jan; 13(1):160-1. PubMed ID: 16426016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neither molecular diversity of the envelope, immunosuppression status, nor proviral load causes indeterminate HTLV western blot profiles in samples from human T-cell lymphotropic virus type 2 (HTLV-2)-infected individuals.
    Olah I; Fukumori LM; Smid J; de Oliveira AC; Duarte AJ; Casseb J
    J Med Virol; 2010 May; 82(5):837-42. PubMed ID: 20336719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
    Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
    J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of signal-to-cutoff values in first, second, and third generation enzyme immunoassays for the diagnosis of HTLV-1/2 infection in "at-risk" individuals from São Paulo, Brazil.
    Jacob F; Magri MC; Costa EA; Santos-Fortuna E; Caterino-de-Araujo A
    J Virol Methods; 2009 Aug; 159(2):288-90. PubMed ID: 19490981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
    Berini CA; Eirin ME; Pando MA; Biglione MM
    J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique.
    Gudo ES; Abreu CM; Mussá T; Augusto Ado R; Otsuki K; Chambo E; Amade N; Tanuri A; Ferreira OC; Jani IV;
    Transfusion; 2009 Jun; 49(6):1146-50. PubMed ID: 19222818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology.
    Vandamme AM; Van Laethem K; Liu HF; Van Brussel M; Delaporte E; de Castro Costa CM; Fleischer C; Taylor G; Bertazzoni U; Desmyter J; Goubau P
    J Med Virol; 1997 May; 52(1):1-7. PubMed ID: 9131450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
    Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil.
    Costa JM; Segurado AC
    J Clin Virol; 2009 Mar; 44(3):185-9. PubMed ID: 19188090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of the confirmatory test of enzyme immunoassay and western blotting method in detection of anti-HTLV-1 in sera].
    Oita T; Fukuda K; Kasakura S
    Rinsho Byori; 1989 Jul; 37(7):774-8. PubMed ID: 2691735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
    Jacob F; Santos-Fortuna E; Azevedo RS; Caterino-de-Araujo A
    J Clin Virol; 2008 Jun; 42(2):149-55. PubMed ID: 18346935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease.
    Soldan SS; Graf MD; Waziri A; Flerlage AN; Robinson SM; Kawanishi T; Leist TP; Lehky TJ; Levin MC; Jacobson S
    J Infect Dis; 1999 Sep; 180(3):685-94. PubMed ID: 10438355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretive criteria used to report western blot results for HIV-1-antibody testing--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Oct; 40(40):692-5. PubMed ID: 1656186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.